The ORATOR trial found no significant difference in survival outcomes between radiation therapy and transoral robotic surgery for HPV-related oropharyngeal cancer. Radiation therapy patients ...
Phase II trial assessing safety, efficacy and immune correlates of heterologous prime-boost with pBI-11 (IM) and TA-HPV (IM) plus pembrolizumab for advanced, PD-L1 CPS≥1, hrHPV+ oropharyngeal cancer.
Compared with standard concurrent chemoradiation, neoadjuvant chemotherapy followed by transoral robotic surgery (NECTORS) and neck dissection led to superior distant metastasis-free and overall ...
A pioneering study at King's College London, University of Oxford and Guy's and St Thomas' NHS Foundation Trust has successfully tested a new robotic surgical system for treating head and neck ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
In the ever-evolving landscape of healthcare technology, robotic surgery has emerged as a groundbreaking innovation, offering unprecedented precision and control in surgical procedures. Leading ...
A trial including 162 patients showed that surgeon-performed transoral/transcervical ultrasonography (USG) achieved a diagnostic accuracy of 86%, outperforming clinical examination and MRI (68% and 76 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results